NASDAQ:PAVM - PAVmed Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $1.07 +0.06 (+5.94 %) (As of 12/14/2018 04:00 PM ET)Previous Close$1.01Today's Range$1.01 - $1.0752-Week Range$0.87 - $3.98Volume176,400 shsAverage Volume336,820 shsMarket Capitalization$27.34 millionP/E Ratio-2.04Dividend YieldN/ABeta-0.21 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email PAVmed Inc. operates as a medical device company in the United States. The company's lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. Its product pipeline also comprises NextCath, a self-anchoring catheter; NextFlo, a disposable infusion system; and Caldus, a disposable tissue ablation device. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was founded in 2014 and is based in New York, New York. Receive PAVM News and Ratings via Email Sign-up to receive the latest news and ratings for PAVM and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:PAVM Previous Symbol CUSIPN/A Webwww.pavmed.com Phone212-949-4319 Debt Debt-to-Equity RatioN/A Current Ratio1.61 Quick Ratio1.61 Price-To-Earnings Trailing P/E Ratio-2.04 Forward P/E Ratio-2.97 P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.22) per share Price / Book-4.86 Profitability EPS (Most Recent Fiscal Year)($0.52) Net Income$-9,510,000.00 Net MarginsN/A Return on Equity-3,311.56% Return on Assets-138.83% Miscellaneous Employees5 Outstanding Shares26,540,000Market Cap$27.34 million OptionableNot Optionable PAVmed (NASDAQ:PAVM) Frequently Asked Questions What is PAVmed's stock symbol? PAVmed trades on the NASDAQ under the ticker symbol "PAVM." How were PAVmed's earnings last quarter? PAVmed Inc (NASDAQ:PAVM) released its quarterly earnings data on Thursday, November, 15th. The company reported ($0.08) EPS for the quarter, topping analysts' consensus estimates of ($0.12) by $0.04. View PAVmed's Earnings History. When is PAVmed's next earnings date? PAVmed is scheduled to release their next quarterly earnings announcement on Wednesday, April 10th 2019. View Earnings Estimates for PAVmed. What price target have analysts set for PAVM? 1 brokers have issued 1-year price targets for PAVmed's stock. Their predictions range from $5.00 to $5.00. On average, they anticipate PAVmed's stock price to reach $5.00 in the next year. This suggests a possible upside of 367.3% from the stock's current price. View Analyst Price Targets for PAVmed. What is the consensus analysts' recommendation for PAVmed? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PAVmed in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for PAVmed. Has PAVmed been receiving favorable news coverage? News headlines about PAVM stock have trended somewhat positive this week, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. PAVmed earned a news sentiment score of 1.2 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the near term. Who are some of PAVmed's key competitors? Some companies that are related to PAVmed include RA Medical Systems (RMED), Sensus Healthcare (SRTS), Apollo Endosurgery (APEN), Arch Therapeutics (ARTH), STRATA Skin Sciences (SSKN), iCAD (ICAD), Endologix (ELGX), Invo Bioscience (IVOB), Pro-Dex (PDEX), Repro-Med Systems (REPR), CAS Medical Systems (CASM), Motus GI (MOTS), SANUWAVE Health (SNWV), Spectral Medical (EDTXF) and Restoration Robotics (HAIR). Who are PAVmed's key executives? PAVmed's management team includes the folowing people: Dr. Lishan Aklog M.D., Chairman & CEO (Age 52)Mr. Dennis M. McGrath CPA, Exec. VP, CFO & Sec. (Age 61)Dr. Brian J. deGuzman M.D., Chief Medical Officer (Age 53)Mr. Shaun M. O'Neil, Chief Commercial Officer Who are PAVmed's major shareholders? PAVmed's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc (1.40%) and Vanguard Group Inc. (1.40%). Company insiders that own PAVmed stock include Dennis M Mcgrath, Ira Scott Greenspan and Lishan Aklog. View Institutional Ownership Trends for PAVmed. Which institutional investors are buying PAVmed stock? PAVM stock was bought by a variety of institutional investors in the last quarter, including Vanguard Group Inc and Vanguard Group Inc.. Company insiders that have bought PAVmed stock in the last two years include Dennis M Mcgrath and Lishan Aklog. View Insider Buying and Selling for PAVmed. How do I buy shares of PAVmed? Shares of PAVM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is PAVmed's stock price today? One share of PAVM stock can currently be purchased for approximately $1.07. How big of a company is PAVmed? PAVmed has a market capitalization of $27.34 million. The company earns $-9,510,000.00 in net income (profit) each year or ($0.52) on an earnings per share basis. PAVmed employs 5 workers across the globe. What is PAVmed's official website? The official website for PAVmed is http://www.pavmed.com. How can I contact PAVmed? PAVmed's mailing address is ONE GRAND CENTRAL PLACE SUITE 4600, NEW YORK NY, 10165. The company can be reached via phone at 212-949-4319 or via email at [email protected] MarketBeat Community Rating for PAVmed (NASDAQ PAVM)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 102 (Vote Outperform)Underperform Votes: 114 (Vote Underperform)Total Votes: 216MarketBeat's community ratings are surveys of what our community members think about PAVmed and other stocks. Vote "Outperform" if you believe PAVM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PAVM will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/14/2018 by MarketBeat.com StaffFeatured Article: How does inflation affect different investments?